These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11884060)

  • 1. Recurrence in the axilla after sentinel lymph node biopsy for breast cancer.
    Salmon RJ; Bouillet TH; Lewis JS; Clough KB
    Eur J Surg Oncol; 2002 Mar; 28(2):199. PubMed ID: 11884060
    [No Abstract]   [Full Text] [Related]  

  • 2. Sentinel lymph node biopsy in breast cancer: a comprehensive literature review.
    Salem A
    J Surg Educ; 2009; 66(5):267-75. PubMed ID: 20005499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-year follow-up after sentinel node mapping for breast cancer demonstrates better than expected treatment outcomes.
    Fuhrman GM; Gambino J; Bolton JS; Farr G; Jiang X
    Am Surg; 2005 Jul; 71(7):564-9; discussion 569-70. PubMed ID: 16089119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer.
    Rosing DK; Dauphine CE; Vargas MP; Gonzalez K; Burla M; Kaufmann P; Vargas HI
    Am Surg; 2006 Oct; 72(10):939-42. PubMed ID: 17058740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Internal mammary chain sentinel biopsy in invasive breast cancer: an investigational procedure?
    García-Villanueva A; Collado-Guirao MV; Rojo-Blanco R; Rioja-Martín ME; Conde-Someso S; Santos-Gomez I; González-Palacios FJ
    Breast J; 2009; 15(3):313-4. PubMed ID: 19645794
    [No Abstract]   [Full Text] [Related]  

  • 6. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
    Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
    J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
    Bulte CS; van der Heiden-van der Loo M; Hennipman A
    Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current role of sentinel node biopsy in the treatment of breast cancer.
    Grube BJ; Giuliano AE
    Adv Surg; 2004; 38():121-66. PubMed ID: 15515617
    [No Abstract]   [Full Text] [Related]  

  • 9. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
    Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
    Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axillary recurrence following sentinel node biopsy for breast cancer.
    Gupta A; Fougo JL
    Eur J Surg Oncol; 2003 Mar; 29(2):198-9; author reply 199. PubMed ID: 12633549
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-axillary breast cancer recurrences after sentinel node biopsy.
    van Rijk MC; Nieweg OE; Valdés Olmos RA; Rutgers EJ; Hoefnagel CA; Kroon BB
    J Surg Oncol; 2005 Dec; 92(4):292-8. PubMed ID: 16299804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel node micrometastases in breast cancer: clinical outcome.
    Kihara SM; Giblett NA; McNeil C; Crea P
    Asia Pac J Clin Oncol; 2010 Dec; 6(4):330-41. PubMed ID: 21114783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration.
    van der Ploeg IM; Kroon BB; Antonini N; Valdés Olmos RA; Rutgers EJ; Nieweg OE
    Ann Surg Oncol; 2008 Apr; 15(4):1025-31. PubMed ID: 18219534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years.
    Domènech A; Benitez A; Bajén MT; Pla MJ; Gil M; Martín-Comín J
    Oncology; 2007; 72(1-2):27-32. PubMed ID: 17998787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
    Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
    Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axillary reverse mapping to prevent lymphedema after breast cancer surgery: defining the limits of the concept.
    Khan SA
    J Clin Oncol; 2009 Nov; 27(33):5494-6. PubMed ID: 19826108
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories.
    Pugliese MS; Beatty JD; Tickman RJ; Allison KH; Atwood MK; Szymonifka J; Arthurs ZM; Huynh PP; Dawson JH
    Ann Surg Oncol; 2009 Jan; 16(1):113-20. PubMed ID: 18949520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer.
    Noguchi M
    Eur J Surg Oncol; 2008 Feb; 34(2):129-34. PubMed ID: 17498911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel node mapping for breast cancer: the operative experience of a breast surgeon in a rural community.
    Davit FE; Gatmaitan P; Garguilo G
    Am Surg; 2008 May; 74(5):423-7. PubMed ID: 18481500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axillary recurrence after negative sentinel lymph node biopsy: frequency and factors influencing recurrence on the long term.
    Sanli I; Lemaire BM; Muller AJ; van Kleffens HJ; Van Poll-Franse LV; van Dijk M
    Breast J; 2009; 15(3):236-41. PubMed ID: 19645777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.